Tumor bearing GCSFR−/− mice had significantly less CFU-GM as compared to WT mice ex vivo (Fig. 2a).
Results of qPCR from samples in Fig. 1g showed that adding lunasin to IL-12 or IL-2 significantly increased expression of GZMB (granzyme B) and CSF2 (granulocyte macrophage colony-stimulating factor or GM-CSF) as compared to treatment with cytokine alone (Fig. 1h).
Once again, in mice where osteophytes were detected, they were significantly smaller following anti-GM-CSF mAb treatment as compared with control mAb treatment (mean size: 267 ± 17 versus 406 ± 14, P < 0.05).
Our study indicates that, at 0.6 V supply voltage and 0.2 V gate-voltage overdrive, TFET exhibits superior variation immunity regarding transconductance to drain current ratio (gm/IDS), output resistance (Rout) and intrinsic gain, and comparable variability in gm and cutoff frequency (fT) as compared with the FinFET counterparts.
Our observations are consistent with the previously observed decrease in granulocyte-macrophage progenitor (CFU-GM) activity in SDS BM as compared to controls, as well as with the observed lowered peripheral blood neutrophil cell counts in SDS patients.
Previous studies had already shown that in human SDS BM granulocyte-macrophage progenitor (CFU-GM) activity is dramatically decreased as compared to control BM cells, clearly indicating defects in the hematopoietic progenitor compartment[4], [28].
Hence, splenocytes from CCL19-treated CC-10 TAg mice had an increase in GM-CSF, CXCL9/MIG, and CXCL10/IP-10 CXCL10/IP-10with diluent-treased comparedg mice.
However, this regression coefficient was not different in magnitude as compared with VAT (9.1 gm, P = 0.65 for β-comparison) or WC (10.3 gm, P = 0.65 for β-comparison) but was smaller than that of BMI (10.6 gm, P = 0.002 for difference between PAT and BMI).
We also confirmed (Bhardwaj et al, 1997) that monocytes activated by short term culture with LPS or with GM-CSF alone or in combination with IL-4, showed enhanced binding of α-MSH (30% for IL-4/GM-CSF and 2 3-fold for GM-CSF or LPS treated monocytes) as compared to control monocytes cultured in medium only.
However, significantly elevated levels of CD40, CD80, CD86, and HLA-DR on CML-DC transduced by CD40-targeted Ad-GM-CSF could be maintained until days 7 14 as compared to CML-DC transduced by untargeted Ad-GM-CSF or CD40-retargeted Ad-CEA.
Recent reports suggest that MoDC cultured in the presence of GM-CSF supplemented with IFNα (IFNα MoDC), as compared to IL-4 (IL-4 MoDC), have an increased capacity to cross-present antigen to CD8+ T cells.
